Sophia Genetics Sa Share Price (NASDAQ: SOPH)

$3.39

▲

0.08

(2.42%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Sophia Genetics Sa Stock chart to analyse performance

Sophia Genetics Sa stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$3.39
Today's High:$3.42
$3.39
0.0%
Downside
Day's Volatility :0.88%
Upside
0.88%
52 Weeks Low:$2.58
52 Weeks High:$4.92
$3.39
23.89%
Downside
52 Weeks Volatility :47.56%
Upside
31.1%

Sophia Genetics Sa Stock Returns

Period	Sophia Genetics Sa	Sector (Health Care)	Index (Russel 2000)
3 Months	17.32%	3.6%	0.0%
6 Months	-4.2%	-7.7%	0.0%
1 Year	-10.7%	-12.6%	0.0%
3 Years	12.13%	9.5%	-4.7%

Sophia Genetics Sa Key Stats

Check Sophia Genetics Sa key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.31
Open	$3.39
Today's High	$3.42
Today's Low	$3.39
Market Capitalization	$225.0M
Today's Volume	$15.0K
52 Week High	$4.92
52 Week Low	$2.58
Revenue TTM	$69.7M
EBITDA	$-65.9M
Earnings Per Share (EPS)	$-1.1
Profit Margin	-105.32%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-74.09%

Stock Returns calculator for Sophia Genetics Sa Stock including INR - Dollar returns

The Sophia Genetics Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sophia Genetics Sa investment value today

Current value as on today

₹93,796

Returns

₹6,204

(-6.2%)

Returns from Sophia Genetics Sa Stock

₹11,488 (-11.49%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Sophia Genetics Sa Stock

-18%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Sophia Genetics Sa Stock from India on INDmoney has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sophia Genetics Sa

Name
Holdings %
Name
Holdings %
Generation Investment Management LLP
10.05%
Akre Capital Management, LLC
5.50%
Banque Pictet & Cie SA
3.27%
Principal Financial Group Inc
2.07%
Millennium Management LLC
0.80%
Archon Capital Management LLC
0.48%

Analyst Recommendation on Sophia Genetics Sa Stock

Rating

Trend

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Sophia Genetics Sa(by analysts ranked 0 to 5 stars)

Sophia Genetics Sa Share Price Target

What analysts predicted

Upside of 106.49%

Target:

$7.00

Current:

$3.39

Sophia Genetics Sa share price target is $7.00, a slight Upside of 106.49% compared to current price of $3.39 as per analysts' prediction.

Sophia Genetics Sa Stock Insights

Price Movement
In the last 7 days, SOPH stock has moved down by -5.3%
Increasing Revenue
Revenue is up for the last 6 quarters, 15.77M → 18.32M (in $), with an average increase of 2.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -15.15M → -22.41M (in $), with an average decrease of 21.8% per quarter
SOPH vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 84.7% return, outperforming this stock by 95.6%
SOPH vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 108.5% return, outperforming this stock by 99.6%
Price to Sales
ForSOPH every $1 of sales, investors are willing to pay $3.3, whereas for Doximity, Inc., the investors are paying $21.6 for every $1 of sales.

Sophia Genetics Sa Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$25.4M	-
Net Income	$-33.8M	-
Net Profit Margin	-133.23%	-

	FY20	Y/Y Change
Revenue	$28.4M	↑ 11.98%
Net Income	$-39.3M	↑ 16.42%
Net Profit Margin	-138.52%	↓ 5.29%

	FY21	Y/Y Change
Revenue	$40.5M	↑ 42.43%
Net Income	$-73.7M	↑ 87.28%
Net Profit Margin	-182.14%	↓ 43.62%

	FY22	Y/Y Change
Revenue	$47.6M	↑ 17.58%
Net Income	$-87.4M	↑ 18.7%
Net Profit Margin	-183.87%	↓ 1.73%

	FY23	Y/Y Change
Revenue	$62.4M	↑ 31.14%
Net Income	$-79.0M	↓ 9.68%
Net Profit Margin	-126.63%	↑ 57.24%

	FY24	Y/Y Change
Revenue	$65.2M	↑ 4.49%
Net Income	$-62.5M	↓ 20.88%
Net Profit Margin	-95.89%	↑ 30.74%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$15.8M	↓ 7.44%
Net Income	$-13.7M	↓ 43.04%
Net Profit Margin	-86.85%	↑ 54.29%

	Q2 FY24	Q/Q Change
Revenue	$15.8M	↑ 0.18%
Net Income	$-15.2M	↑ 10.87%
Net Profit Margin	-96.11%	↓ 9.26%

	Q3 FY24	Q/Q Change
Revenue	$15.9M	↑ 0.28%
Net Income	$-18.4M	↑ 21.36%
Net Profit Margin	-116.31%	↓ 20.2%

	Q4 FY24	Q/Q Change
Revenue	$17.7M	↑ 11.86%
Net Income	$-15.2M	↓ 17.79%
Net Profit Margin	-85.48%	↑ 30.83%

	Q1 FY25	Q/Q Change
Revenue	$17.8M	↑ 0.26%
Net Income	$-17.4M	↑ 14.69%
Net Profit Margin	-97.78%	↓ 12.3%

	Q2 FY25	Q/Q Change
Revenue	$18.3M	↑ 3.06%
Net Income	$-22.4M	↑ 28.93%
Net Profit Margin	-122.33%	↓ 24.55%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$17.8M	-

	FY20	Y/Y Change
Profit	$17.7M	↓ 0.78%

	FY21	Y/Y Change
Profit	$25.2M	↑ 42.56%

	FY22	Y/Y Change
Profit	$31.3M	↑ 23.92%

	FY23	Y/Y Change
Profit	$42.9M	↑ 37.3%

	FY24	Y/Y Change
Profit	$43.9M	↑ 2.39%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$10.4M	↓ 12.56%

	Q2 FY24	Q/Q Change
Profit	$10.8M	↑ 3.57%

	Q3 FY24	Q/Q Change
Profit	$10.7M	↓ 1.13%

	Q4 FY24	Q/Q Change
Profit	$12.1M	↑ 13.59%

	Q1 FY25	Q/Q Change
Profit	$12.2M	↑ 0.88%

	Q2 FY25	Q/Q Change
Profit	$12.3M	↑ 0.51%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-31.7M	-
Investing Cash Flow	$-3.0M	-
Financing Cash Flow	$-1.0M	-

	FY20	Y/Y Change
Operating Cash Flow	$-31.7M	↑ 0.16%
Investing Cash Flow	$-24.3M	↑ 701.95%
Financing Cash Flow	$107.0M	↓ 10563.83%

	FY21	Y/Y Change
Operating Cash Flow	$-57.9M	↑ 82.6%
Investing Cash Flow	$-56.9M	↑ 134.07%
Financing Cash Flow	$237.8M	↑ 122.12%

	FY22	Y/Y Change
Operating Cash Flow	$-70.1M	↑ 20.98%
Investing Cash Flow	$42.0M	↓ 173.72%
Financing Cash Flow	$-1.6M	↓ 100.66%

	FY23	Y/Y Change
Operating Cash Flow	$-48.6M	↓ 30.7%
Investing Cash Flow	$8.3M	↓ 80.18%
Financing Cash Flow	$-2.8M	↑ 79.66%

	FY24	Y/Y Change
Operating Cash Flow	$-42.8M	↓ 11.84%
Investing Cash Flow	$-8.2M	↓ 198.27%
Financing Cash Flow	$11.6M	↓ 511.25%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-13.8M	↑ 25.84%
Investing Cash Flow	$-2.0M	↓ 18.51%
Financing Cash Flow	$-596.0K	↑ 22.82%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-9.6M	↓ 30.57%
Investing Cash Flow	$-1.9M	↓ 3.33%
Financing Cash Flow	$13.1M	↓ 2304.34%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-8.4M	↓ 12.77%
Investing Cash Flow	$-2.3M	↑ 22.62%
Financing Cash Flow	$-593.0K	↓ 104.51%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-10.6M	↑ 26.47%
Investing Cash Flow	$-1.9M	↓ 16.42%
Financing Cash Flow	$-573.0K	↓ 3.37%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-10.8M	↑ 1.41%
Investing Cash Flow	$-1.0M	↓ 46.44%
Financing Cash Flow	$-990.0K	↑ 72.77%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-9.3M	↓ 13.39%
Investing Cash Flow	$-2.1M	↑ 104.81%
Financing Cash Flow	$35.7M	↓ 3705.4%

Sophia Genetics Sa Technicals Summary

Sell

Neutral

Buy

Sophia Genetics Sa is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sophia Genetics Sa Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sophia Genetics Sa	8.23%	-4.2%	-10.7%	12.13%	-79.59%
Tempus Ai	38.06%	48.79%	45.48%	88.27%	88.27%
Doximity, Inc.	18.52%	-0.73%	89.28%	107.86%	28.21%
Ge Healthcare Technologies Inc.	5.57%	-14.7%	-13.04%	21.9%	21.9%
Veeva Systems Inc.	-4.29%	22.99%	24.82%	57.09%	-8.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sophia Genetics Sa	NA	NA	NA	-0.87	-0.74	-0.23	NA	1.14
Tempus Ai	34.26	34.26	NA	-0.73	-0.98	-0.12	NA	1.78
Doximity, Inc.	57.96	57.96	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	15.11	15.11	3.44	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	55.28	55.28	1.4	6.45	0.14	0.07	NA	40.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sophia Genetics Sa	Buy	$225.0M	-79.59%	NA	-105.32%
Tempus Ai	NA	$12.8B	88.27%	34.26	-20.98%
Doximity, Inc.	Hold	$12.7B	28.21%	57.96	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.9B	21.9%	15.11	11.22%
Veeva Systems Inc.	Buy	$44.0B	-8.43%	55.28	27.29%

About Sophia Genetics Sa

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.

Organization	Sophia Genetics Sa
Employees	423
CEO	Dr. Jurgi Camblong M.B.A., Ph.D.
Industry	Technology

Key Management of Sophia Genetics Sa

Name	Title
Dr. Jurgi Camblong M.B.A., Ph.D.	Co-Founder, CEO & Director
Mr. Ross Jordan Muken B.Sc.	President
Mr. George A. Cardoza M.B.A.	Executive VP & CFO
Mr. Abhimanyu Verma	Senior VP & CTO
Dr. Zhenyu Xu Ph.D.	Executive VP & Chief Scientific Officer
Kellen Sanger	Head of Strategy and Investor Relations
Mr. Daan van Well L.L.M., M.B.A.	Executive VP, Chief Legal & Regulatory Officer
Ms. Manuela Da Silva Valente B.A.	Executive VP & Chief People Officer
Mr. Kevin Puylaert	VP & MD of EMEA
Dr. Philippe Menu M.B.A., M.D., Ph.D.	Executive VP, Chief Medical Officer & Chief Product Officer

Important FAQs about investing in SOPH Stock from India :

What is Sophia Genetics Sa share price today?

Sophia Genetics Sa share price today is $3.39 as on August 30, 2025 at 1:29 am IST at the close of the market. Sophia Genetics Sa share today touched a day high of $3.42 and a low of $3.39.

What is the 52 week high and 52 week low for Sophia Genetics Sa share?

Sophia Genetics Sa share touched a 52 week high of $4.92 and a 52 week low of $2.58. Sophia Genetics Sa stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $3.39, lower by 31.1% versus the 52 week high.

How to invest in Sophia Genetics Sa Stock (SOPH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sophia Genetics Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sophia Genetics Sa Shares that will get you 0.4425 shares as per Sophia Genetics Sa share price of $3.39 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Sophia Genetics Sa Stock (SOPH) from India?

Indian investors can start investing in Sophia Genetics Sa (SOPH) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Sophia Genetics Sa stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Sophia Genetics Sa share’s latest price of $3.39 as on August 30, 2025 at 1:29 am IST, you will get 2.9499 shares of Sophia Genetics Sa. Learn more about fractional shares .

What are the returns that Sophia Genetics Sa has given to Indian investors in the last 5 years?

Sophia Genetics Sa stock has given -79.59% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?